KSAWorks
KSAWorks
Knowledge • Skills • Abilities
Hampton University · Courses

PHA

187 courses with the subject PHA, each shown exactly as we captured it from the college's catalog, with every element we hold. Where the wording looks broken, that is our reading of the catalog, not the college's text.

PHA 300Quantitative

Laboratory Techniques Lab. 2./Credit 2. This course will introduce the theory of the classical and modern labora- tory to accurately determine the concentration, amount, or percentage of one or more elements of pharmaceuticals. The course content will cover the following areas: l) laboratory skills in design and in performing a quantita- tive chemical and biological analysis; 2) the technique in laboratory data collection and recording in pharmaceutical laboratories; 3) the Importance of accuracy and precision of laboratory results; and 4) the interpretation and critical evaluation of the experimental results. Prerequisite(s): CHE 302

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 301Pharmaceutical Care I Lec. 3./Credit 3

This is the first class in a series of coursework where students will be introduced to the concepts of pharmaceutical care, profession- alism and the potential challenges of applying them to a practice setting. This course will also provide students with basic computer skills and basic drug information retrieval and assessment strate- gies. This course includes an early practice experience. Course Descriptions – Main Campus 361

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 302Pharmaceutical Care II Lec. 3./Credit 3

This course provides the student with foundational concepts nec- essary to understand the practice of pharmaceutical care. Empha- sis will be placed on understanding introductory, select laboratory values, principles of basic disease states, fundamentals of the patient medical chart, SOAP concepts, and methods for evaluat- ing case studies. Students will also gain experience with oral and written presentations. Select concepts of professionalism and drug information will also be emphasized. This course includes an early practice experience. Prerequisite: Successful completion of PHA 301.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 303Introduction to

Pharmacy Practice Lec. 2./Credit 2. This course provides the student with an introduction to pharmacy practice experiences. Students will be exposed to developmental topics, learn how the pharmacy runs, and become oriented to the workflow and layout of the dispensing area, all of which prepare students for their Introductory Pharmacy Practice Experiences. This course will also serve as an introduction to over- the-counter medications and products as well as the top 200 drugs.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 305Applied Human Physiology Lec. 3./Credit 3

This course will introduce the fundamental principles of human physiology. Concepts are reviewed using systems-based approach, with particular emphasis on cellular physiology, neuroendocrine, renal, and cardiovascular system physiology. Basic principles of pathophysiology and human disease will be introduced. Prerequisite(s): BIO 224 and 225 or BIO 336 or with consent of the Department Chairperson.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 307Principles of Pharmacology Lec. 1./Credit 1

This course will provide students with a fundamental understanding of how medications interact with biological systems as well as the basic rationale behind the design and utilization of drugs in disease states. An introduction to core principles of pharmacology will be discussed, including receptor biology and signal transduction pathways, basic pharmacokinetics and pharmaco- dynamics, routes of administration, drug metabolism and transport, drug therapy in special population, principles of drug targeting and drug develop- ment and basic pharmacogenomics. Prerequisite(s): CHE 302, BIO 224 and BIO 225 or BIO 336 or with the consent of the Department Chairperson.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 308Pharmacology

& Pathophysiology I Lec. 4./Credit 4. This sequence of courses is organized by disease states/organ systems and provides each student with basic knowledge of pathophysiology and pharma- cology, thus enabling them to manage disease states, establish rational treatment and realistic outcomes, and provide parameters to monitor the progression of disease. Prerequisite(s): PHA 305 or PHA 505, PHA 307 or PHS 307, and PHA 311 or PHS 511.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 310Medical Immunology Lec. 2./Credit 2

This course will discuss the function of the immune system, including mecha- nisms of human immune function, and the immunologic basis of oncologic and autoimmune diseases, immunodeficiency, hypersensitivities and allergic reactions. Prerequisite(s): undergraduates BIO 224 and 225 or BIO 336; PharmD majors PHA 305.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 311Physiological Chemistry Lec. 3./Credit 3

This course provides an overview of the chemical and physical properties of biomolecules, including carbohydrates, proteins, enzymes, lipids, nucleic acids, and vitamins. It focuses on the rela- tionship of organic functional groups to these properties and their role in the activity of drugs. The course also focuses on intermedi- ary metabolism and chemical interconversions in living systems.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 312Drug Discovery, Design

and Development Lec. 3./Credit 3. This course will provide students with a fundamental knowledge of drug discovery, design, and development with a pre-clinical focus. This knowl- edge includes both conventional, historical, and contemporary approaches to sourcing and developing new drugs, from natural sources through to rational drug design, lead optimization, and both in vitro and in vivo screening approaches for drug efficacy and safety, including computer-based methods, combinatorial chemistry, and high-throughput screening. Prerequisite(s): CHE 302.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 314Medicinal Chemistry I Lec. 4./Credit 4

The focus of this two-course sequence is the chemistry of natural and synthetic drug entities, their physicochemical properties, methods of synthesis, sources, derivatives, modes of biotransformation, and structure activity relationships. In this course, a concerted effort is made to link the chemical structure of drugs to their pharmaco- logical/pharmacokinetic/toxicity profiles. Prerequisites: PHA 311 or PHS 511.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 315Pharmacists’ Patient Care

Process (PPCP) Lec. 3/Credit 3. This course will introduce the concept of patient-centered care, and how to apply the pharmacists’ patient care process to optimize health and medica- tion outcomes. The particular focus of this course will be on collecting and assessing subjective patient data, including developing patient interviewing skills, review of health records and methods of medical documentation, with an emphasis on the importance of utilizing the data to formulate, implement, and follow-up on a care plan.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 316Principles of Drug Information Lec. 3./Credit 3

Drug information and informatics will be the primary focus of this course. Principles of drug information, drug information retrieval and analysis, litera- ture evaluation, and verbal and written communication skills will be empha- sized. Students will be able to utilize the drug information skills learned in this course to provide optimal pharmaceutical care in any pharmacy practice setting. Prerequisite(s): MAT 205, PHA 307 or PHS 507

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 317Pharmaceutical Analysis Lab 3./Credit 3

This course explores the fundamentals of pharmaceutical analysis techniques and their applications in pharmaceutical research and development (both academic and industrial). Students receive a solid conceptual ground to understand the utility of particular analytical methods. It enables students to evaluate instrumentation choices when needed critically and to select the appropriate tools. Prerequisite(s): CHE 302

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 318Responsible Conduct of Research Lec. 1./Credit 1

This course familiarizes students with fundamental ethical issues in research. Course goals include l) gaining insights into responsible conduct of research, 2) acquiring knowledge on how to address the ethical problems appropriately, and 3) comprehending ethical issues and how to mitigate these situations. The seminars explore the best practices in research and experimental design, authorship, data management and record-keeping, intellectual property and ownership of data, as well as research misconduct and rigor and transpar- ency, and discussion sessions focusing on ethical considerations for human and animal research subjects, conflicts of interest, mentoring, collaborations, peer review, laboratory safety, and research training, and environmental and societal impacts of scientific research. Note: This course meets or exceeds recent NIH Updates on the Requirement for Instruction in the Responsible Conduct of Research (NOT-OD-10-019; requirements for instruction in the responsible conduct of research. Prerequisite(s): BIO 224 or with the consent of the department chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 319Pharmaceutical Calculations I Lec. 2./Credit 2

Pharmaceutical Calculations I will provide students with their first exposure to basic pharmaceutical calculations. This course is designed to provide students with information about basic medication orders/prescriptions and the mathematical calculations and abbreviations needed for interpretation of prescriptions. Prerequisite(s): MAT 130 and MAT 205 Course Descriptions – Main Campus 353

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 320Pharmaceutical Calculations I

 Lec. 2./Credit 2. Pharmaceutical Calculations I will provide students with their first exposure to basic pharmaceutical calculations. This course is designed to provide students with information about basic medi- cation orders/prescriptions and the mathematical calculations and abbreviations needed for interpretation of prescriptions.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 321Anatomy/Physiology with Lab

 Lec. 4./Lab 1./Credit 5. Lectures, laboratories and demonstrations are designed to acquaint the student with the basic structure of the human body and the fundamental principles of human physiology. Concepts are taught which integrate physiology and pathophysiology . The course is organized according to the following systems: cellular physiology, neurophysiology, cardiovascular, respiratory, renal gastrointestinal and endocrine physiology.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 326Pharmaceutical Calculations II Lec. 1./Credit1

This course will continue to develop student knowledge by application of basic pharmaceutical calculations. Also, students will be introduced to basic clinical and pharmacokinetic calculations. Prerequisite(s): PHA 319 or PHS 526

Subject
PHA
Credits (min)
1
Credits (max)
1
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 330Introduction to Pharmacy Practice

 Lec. 2./Credit 2. This course provides the student with an introduction to pharmacy practice experiences. Students will be exposed to developmental topics, learn how the pharmacy runs, and become oriented to the workflow and layout of the dispensing area, all of which prepare students for their Introductory Pharmacy Practice Experiences. This course will also serve as an introduction to over-the-counter medi- cations and products as well as the top 200 drugs. 362 Course Descriptions – Main Campus

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 332Biostatistics & Epidemiology Lec. 3./Credit 3

This course is an introductory class to basic statistical concepts, methods, and medical literature evaluation techniques. Students will learn the skills necessary to understand and analyze today’s medical literature. The goal of the course is to expose students to biostatistical concepts by using examples of the clinical applica- tion of the concepts in drug literature evaluation. The course will introduce students to the application of statistics using SPSS® and Microsoft Excel and other common statistical packages that are currently available.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 361Biopharmaceutics I with Lab

 Lec. 4./Lab 1./Credit 5. This course is designed to help students to understand physico- chemical and biological factors, which affect the stability, kinetics, bioavailability and bioequivalence of drugs in dosage forms. It will also focus on the design, preparation, evaluation and use of liquid dosage forms. Calculations, metrology, and laboratory exercises are also emphasized.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 362Biopharmaceutics II with Lab

 Lec. 4./Lab 1./Credit 5. This course is designed to help students to understand the physi- cochemical and biological factors which affect the bioavailability of drugs from dosage forms, and application of this knowledge to dosage form design, formulation, and drug delivery systems. It will also focus on the theory, technology, formulation, evaluation, and dispensing of solid and semi-solid dosage forms. Calculations, metrology and laboratory exercises are also emphasized.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 370Community IPPE Credit 1

An Introductory Pharmacy Practice Experience (IPPE) is designed to assist the student in actively participating in and experiencing the distributive functions of pharmacy in the community pharmacy practice setting. The commu- nity pharmacy practice setting experience is divided into six main areas of experience: prescription processing and compounding, over-the-counter products, patient counseling and education, pharmacy administration and management, pharmacy law, and team interaction/education. Prerequisite(s): Successful completion of all P1 level didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 371Biopharmaceutics I Lec. 3./Credit 3

This course is designed to help students to understand physico-chemical and biological factors, which affect the stability, kinetics, bioavailability and bioequivalence of drugs in dosage forms. It will also focus on the design, preparation, evaluation and use of liquid dosage forms. Calculations, metrology, and laboratory exercises are also emphasized. Prerequisite(s): undergraduates PHA 300 or PHS 300, PHA 312 or PHS 312, and PHA 317 or PHS 317; PharmD majors BIO 224 and BIO 225 or BIO 336. Corequisite(s): PHA 373 or PHS 573

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 372Biopharmaceutics II Lec. 3./Credit 3

This course is designed to help students to understand physico-chemical and biological factors, which affect the stability, kinetics, bioavailability and bioequivalence of drugs in dosage forms. It will also focus on the design, preparation, evaluation and use of liquid dosage forms. Calculations, metrology, and laboratory exercises are also emphasized. Prerequisite(s): PHA 371 or PHS 571 and PHA 373 or PHS 573; Corequisite(s): PHA 374 or PHS 574

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 373Biopharmaceutics I Lab Lab. 3./Credit 1

This course is designed to help students to understand physico-chemical and biological factors, which affect the stability, kinetics, bioavailability and bioequivalence of drugs in dosage forms. It will also focus on the design, preparation, evaluation and use of liquid dosage forms. Calculations, metrology, and laboratory exercises are also emphasized. Prerequisite(s): undergraduates PHA 300 or PHS 300, PHA 312 or PHS 312, and PHA 317 or PHS 317; PharmD majors BIO 224 and BIO 225 or BIO 336; Corequisite(s): PHA 371 or PHS 571

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 374Biopharmaceutics II Lab Lab. 3./Credit 1

This course is designed to help students to understand physico-chemical and biological factors, which affect the stability, kinetics, bioavailability and bioequivalence of drugs in dosage forms. It will also focus on the design, preparation, evaluation and use of liquid dosage forms. Calculations, metrology, and laboratory exercises are also emphasized. Prerequisite(s): PHA 371 or PHS 571 and PHA 373 or PHS 573; Corequisite(s): PHA 372 or PHS 572

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 399Research Internship Credit 1./Credit 1

By arrangement with a selected research setting, students engage in a super- vised research experience.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 401Pharmaceutical Care III Lec. 3./Credit 3

This course is designed to expose second year professional phar- macy students to advanced concepts of pharmaceutical care. Emphasis is placed on developing skills necessary to effectively communicate in pharmacy practice environments. This course will challenge students to acquire the skills necessary to successfully conduct patient assessment, develop pharmaceutical care plans, manage patient follow-up evaluations, and provide pharmaco- therapy education. Prerequisite: Successful completion of all P-1 level courses. Hampton University 2018-2020

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 402Pharmaceutical Care IV Lec. 3./Credit 3

Drug information and informatics will be the primary focus of this course. Principles of drug information, drug information retrieval and analysis, literature evaluation, and verbal and written commu- nication skills will be emphasized. Students will be able to utilize the drug information skills learned in this course to provide optimal pharmaceutical care in any pharmacy practice setting. Prerequi- site: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 405Pharmacology &

Pathophysiology II Lec. 4./Credit 4. This sequence of courses is organized by disease states/organ systems and provides each student with basic knowledge of pathophysiology and pharma- cology, thus enabling them to manage disease states, establish rational treatment and realistic outcomes, and provide parameters to monitor the progression of disease. Prerequisite(s): Successful completion of all P1 level didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 406Pharmacology &

Pathophysiology III Lec. 4./Credit 4. This sequence of courses are organized by disease states/organ systems and provide each student with basic knowledge of pathophysiology and pharma- cology, thus enabling them to manage disease states, establish rational treatment and realistic outcomes, and provide parameters to monitor the progression of disease. Prerequisite(s): PHA 405 or PHA 605 354 Course Descriptions – Main Campus

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 410Therapeutics I Lec. 3./Credit 3

This systems-based course series will develop student knowledge and skills for therapeutic management of disease, based on application of medicinal chemistry, pharmacology, physiology, and pathophysiology concepts. The first course in this series will review selected diseases of the gastrointes- tinal system and nutrition, and discuss strategies for patient evaluation and treatment. Prerequisite(s): Successful completion of all P1 and P2 level Fall semester didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 412Therapeutics II Lec. 3/Credit 3

This systems-based course series will develop student knowledge and skills for therapeutic management of disease, based on application of medicinal chemistry, pharmacology, physiology, and pathophysiology concepts. The second course in this series will review selected neurological and psychi- atric diseases, and discuss strategies for patient evaluation and treatment. Prerequisite(s): Successful completion of all P1 and P2 level Fall semester didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 414Medicinal Chemistry II Lec. 4./Credit 4

The focus of this two-course sequence is the chemistry of natural and synthetic drug entities, their physicochemical properties, methods of synthesis, sources, derivatives, modes of biotransformation, and structure activity relationships. In this course, a concerted effort is made to link the chemical structure of drugs to their pharmacological/pharmacokinetic/ toxicity profiles. Prerequisites: PHA 413 Successful completion of all P-1 level courses. Prerequisite(s): Successful completion of all P1 level didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 415Pharmacists’ Patient Care

Process (PPCP) Lec. 3/Credit 3. This course will introduce the concept of patient-centered care, and how to apply the pharmacists’ patient care process to optimize health and medica- tion outcomes. The particular focus of this course will be on collecting and assessing subjective patient data, including developing patient interviewing skills, review of health records and methods of medical documentation, with an emphasis on the importance of utilizing the data to formulate, implement, and follow-up on a care plan. Prerequisite(s): Successful completion of all P1 level didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 416Biostatistics

and Research Methods Lec. 3./Credit 3 This course introduces students to the basic concepts of biostatistics and research. Basic concepts will include understanding the research question, hypothesis, methodology, data collection and analysis, results, and conclu- sion. Students will develop and write a mini proposal that encompasses these basic principles. This proposal will be implemented and completed by the end of the course. Students will also gain experience with writing abstracts and developing scientific posters to present findings of research studies. Prereq- uisite: undergraduates MAT 205; PharmD majors successful completion of all P1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 417PPCP Skills Lab Lab 3./Credit 1

This course will develop knowledge and skills in pharmacist patient assess- ment techniques. Students will learn to perform basic patient subjective and objective assessment related to provision of patient care, including patient interviewing, obtaining medical history, vital signs assessment, and point-of- care testing. Prerequisite(s): Successful completion of all P1 and P2 level Fall semester didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 418Applied Therapeutics Laboratory I Lab 3/Credit 1

In this course series, students will apply knowledge of the pharmacist’s patient care process to formulate, implement, and follow-up on a care plan for the disease management of patient case-based scenarios across a variety of clinical settings. Disease states discussed will be integrated with concurrent topics assessed in the Therapeutics I—II course series. As the course series progresses, increasing complexity will be applied, incorporating comorbidi- ties and complicated patient courses based on previously acquired pharma- cotherapy knowledge. Prerequisite(s): Successful completion of all P1 and P2 level Fall semester didactic courses. Hampton University 2026-2028

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 420Principles of Toxicology Lec. 2./Credit 2

This course provides the basic concepts of toxicology. This course also serves to alert pharmacy students to commonly occurring exposures; to instruct students as to what symptoms are presented and the actions or recom- mendations to make in instances of accidental poisoning. Prerequisite(s): Successful completion of all P1 level didactic courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 423Microbiology/Immunology Lec. 3./Credit 3

This course is designed to provide an overview of the interactions between host and pathogens in infectious diseases. It will focus on microbial organization, growth, metabolism, reproduction, and genetic variation. The course will also provide an overview of the immune system and its role in disease management. Prerequisite: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 431Healthcare Administration I Lec. 2./Credit 2

This course focuses on the structure and organization, delivery, regulation, and financing of the American healthcare system. Pharmacy, its role and responsibilities in the healthcare system, public health, and its interaction with other health occupations is discussed. Reimbursement issues in health- care are introduced and implications upon the practice of health care are discussed. This course covers the functions of management and administra- tion (planning, organization, staffing, direction, and controlling) applied to pharmacy practice in the community and institutional settings. Contemporary management principles for the solution of these problems are discussed, in addition to introduction to basic management principles and methods; and entrepreneurial, social and economical aspects of practice. Prerequisite: Successful completion of all P-1 level courses. Prerequisite(s): Successful completion of all P1 level didactic courses or the consent of the department chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 432Healthcare Administration/Management II

 Lec. 3./Credit 3. This course will provide the students pharmacy management prin- ciples that relate to contemporary pharmacy practice and present an introduction to the fundamentals of health outcomes research and pharmacoeconomic analysis. The overall goals of this course are to familiarize the student and provide basic tools in order to develop and deliver patient-centered pharmaceutical care ser- vices. Students will be exposed to pharmacoeconomic articles and participate in discussions which will provide them with tools use- ful to address the difficulties associated with implementing pro- grams. Through an active learning process, students will follow and interpret current issues that are shaping pharmaceutical and medical care as they discover the impact these events will have in shaping their future practice. Prerequisite: Successful completion of all P-1 level courses. Hampton University 2018-2020

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 433General Pharmacology I Lec. 3./Credit 3

This course provides students with a fundamental understanding of how medications interact with biological systems as well as the primary ratio- nale behind the design and utilization of drugs in disease states. The course content will focus on the core principles of pharmacology. Topics include receptor biology and signal transduction pathways, basic pharmacoki- netics and pharmacodynamics, routes of administration, drug metabolism and transport, drug therapy/toxicology in special populations, principles of drug targeting and drug development, and basic pharmacogenomics. Prerequisite(s): CHE 302, BIO 224 & 225 or BIO 336

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 434General Pharmacology Il Lec. 3./Credit 3

The course provides each student with basic knowledge of pathophysiology and pharmacology, organized by disease states and organ systems. This approach enables students to manage disease states, establish rational treat- ment and realistic outcomes, and provide parameters to monitor the progres- sion of the disease. Prerequisite(s): PHA 433

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 461Pharmacokinetics Lec. 4./Credit 4

This course is designed to provide the essential skills for employing pharma- cokinetic principles in the selection and evaluation of drug therapy. It will focus on principles of drug therapy, evaluation, selection, and therapeutic monitoring with emphasis on clinically functional approaches to the design of dose regimens, and pharmacokinetics of select drugs in special patient populations and disease states. This course includes a required calculations laboratory period. Prerequisite: Successful completion of all P-1 level courses. Prerequisite(s): Successful completion of all P1 level didactic courses;

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
Corequisite
PHA 462.
PHA 462Pharmacokinetics Laboratory Lab 3./Credit 1

This course is designed to provide the essential skills for employing pharma- cokinetic principles in the selection and evaluation of drug therapy. It will focus on principles of drug therapy, evaluation, selection, and therapeutic monitoring with emphasis on clinically functional approaches to the design of dose regimens, and pharmacokinetics of select drugs in special patient populations and disease states. This course includes a required calculations laboratory period. Prerequisite: Successful completion of all P-1 level courses. Prerequisite(s): Successful completion of all P1 level didactic courses;

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
Corequisite
PHA 461.
PHA 463Pharmacokinetics Lec. 5./Credit 5

This course is designed to provide the essential skills for employ- ing pharmacokinetic principles in the selection and evaluation of drug therapy. It will focus on principles of drug therapy, evaluation, selection, and therapeutic monitoring with emphasis on clinically functional approaches to the design of dose regimens, and phar- macokinetics of select drugs in special patient populations and dis- ease states. This course includes a required calculations laboratory period. Prerequisite: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 470Institutional IPPE Credit 1

An introductory pharmacy practice experience (IPPE) designed to assist the student in actively participating in and experiencing the distributive functions of pharmacy in the institutional pharmacy practice settings. The institutional pharmacy practice experience is divided into seven main areas of experience: drug distribu- tion, manufacturing activities, dissemination of drug and product information, patient counseling and education, pharmacy admin- istration and management, pharmacy law, and team interaction/ education. Prerequisites: Successful completion of all P-2 level didactic courses. PHA 480,482,484,581,583,585,586,588 Drug and Disease Management I-VIII  Lec. 3 or 4./Credit 3 or 4. This sequence of courses is an integrated course that emphasizes a patient focused, systematic management of disease through appropriate therapeutic regimens. These modules are organized by disease states/organ systems and provide each student with basic knowledge of pathophysiology, pharmacology and therapeutics, thus enabling them to manage disease states, establish rational treatment and realistic outcomes, and provide parameters to moni- tor the progression of disease. Prerequisites for PHA 480, 482, and 484: Successful completion of all P-1 level courses and all P-2 Fall semester courses; Prerequisites for PHA 581, 583, 585, 586, and 588: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 490Introduction to Clerkships Lec. 2./Credit 2

This course provides the student with an introduction to advanced clinical practice. Students will participate in medical rounds, con- ferences, and seminars. He or she will be expected to monitor patient therapy and evaluate the appropriateness of drug therapy. This course in an intermediate practice experience. Prerequisites: Successful completion of all P-1 level courses and PHA 401.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 499Research Capstone Credit

This course will teach students how to write a research paper and present research findings obtained during the student’s Research Internship course or Independent Study course. This course will also prepare students for entry into the workforce or application to graduate or professional school through career development activities. Prerequisite(s): PHA 399 or PHS 399 or with the consent of the department chair

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 501Self-Care and Non-prescription

Therapies Lec. 3./Credit 3. This course is designed to familiarize the student with nonprescription drugs and products or over-the-counter medications. Emphasis will be placed on the pharmacology of the drugs, potential disease states in which the drugs are utilized, self-administration techniques, consideration in selection of a product, and patient counseling. Prerequisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 502Pharmacy Practice Lec. 2./Credit 2

This course provides the student with an introduction to pharmacy practice experiences. Students will learn the history of pharmacy, pharmacy opera- tions including workflow orientation and layout of the dispensing area, all of which prepare students for Introductory Pharmacy Practice Experiences (IPPE) and introduce the concepts of ethics, communication and medical terminology. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 504Top 200 Medications Lec. 2./Credit 2

This course involves the study of the top 200 most commonly prescribed drugs. Students will learn trade names, generic names, available strengths, available dosage forms, indications and appropriate dosing guidelines, common adverse drug reactions, patient counseling information and clini- cally significant drug-drug interaction. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 505OTC & Alternative Therapy

TOTAL 18 Second Professional Year Semester 1st

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 506Pharmaceutical Calculations Lec. 2. /Credit 2

This course will provide students with their first exposure to basic pharma- ceutical calculations. This course is designed to provide students with infor- mation about basic medication orders/prescriptions and the mathematical calculations and abbreviations needed for interpretation of prescriptions. This course will continue to develop student knowledge by application of basic pharmaceutical calculations. Also, students will be introduced to basic clinical and pharmacokinetic calculations. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 510Principles of Biomedical

Science w/Lab Lec. 5. /Lab.0. /Credit 5. This course will reinforce the fundamental principles of human physiology by providing a solid foundation in the areas of genetics, anatomy, biochemistry, human, molecular as well as cellular physiology. The course will stress the interrelationships between normal biological processes, basic genetic and biochemical factors that contribute to the development of diseases, as well as pharmacological rationales for targeting bio-macromolecules and signaling pathways. This course will employ problem-based and team-based learning approaches 1) to engage students, 2) to expand students’ understanding of the integrated functions of the organ systems; 3) and to improve students’ critical thinking as well as decision-making skills required for successful completion of clinical and advanced science courses. Prerequisite(s): CHE 302, BIO 224 and BIO 225 or BIO 336 or with the consent of the Department Chairperson. Course Descriptions – Main Campus 355

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 511Therapeutics III Lec. 4./Credit 4

This systems-based course series will develop student knowledge and skills for therapeutic management of disease, based on application of medicinal chemistry, pharmacology, physiology, and pathophysiology concepts. The third course in this series will review selected diseases of the respiratory system and cardiovascular system, and discuss strategies for patient evalua- tion and treatment. Prerequisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 513Therapeutics IV Lec. 4./Credit 4

This systems-based course series will develop student knowledge and skills for therapeutic management of disease, based on application of medicinal chemistry, pharmacology, physiology, and pathophysiology concepts. The fourth course in this series will review selected diseases of the renal system and endocrine system and discuss strategies for patient evaluation and treat- ment. Prerequisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 515Principles of Drug Design Lec. 2./Credit 2

This course is designed to provide the interested student with specific infor- mation concerning those concepts and techniques involved in the identifi- cation and preparation of new drug entities. Successful completion of this course would provide the student with advanced knowledge concerning the chemical aspects of drug action and toxicity.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 516Therapeutics V Lec. 3./Credit 3

This systems-based course series will develop student knowledge and skills for therapeutic management of disease, based on application of medicinal chemistry, pharmacology, physiology, and pathophysiology concepts. The fifth course in this series will review selected infectious diseases, and discuss strategies for patient evaluation and treatment. Prerequisite: Successful completion of all P-1 and P-2 level courses and P-3 Fall semester courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 517Applied Therapeutics

Laboratory II Lab. 3./Credit 1. In this course series, students will apply knowledge of the pharmacist’s patient care process to formulate, implement, and follow-up on a care plan for the disease management of patient case-based scenarios across a variety of clinical settings. Disease states discussed will be integrated with concurrent topics assessed in the Therapeutics III—IV course series. As the course series progresses, increasing complexity will be applied, incorporating comorbidi- ties and complicated patient courses based on previously acquired pharma- cotherapy knowledge. Prerequisite: Successful completion of all P-1 and P-2 level courses ans P-3 Fall semester courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 518Therapeutics VI Lec. 3./Credit 3

This systems-based course series will develop student knowledge and skills for therapeutic management of disease, based on application of medicinal chemistry, pharmacology, physiology, and pathophysiology concepts. The final course in this series will review selected rheumatologic, hematologic, and oncologic diseases, and discuss strategies for patient evaluation and treatment. Prerequisite: Successful completion of all P-1 and P-2 level courses ans P-3 Fall semester courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 520Applied Therapeutics

Laboratory III Lab. 3./Credit 1. In this course series, students will apply knowledge of the pharmacist’s patient care process to formulate, implement, and follow-up on a care plan for the disease management of patient case-based scenarios across a variety of clinical settings. Disease states discussed will be integrated with concurrent topics assessed in the Therapeutics V-VI course series. As the course series progresses, increasing complexity will be applied, incorporating comorbidi- ties and complicated patient courses based on previously acquired pharma- cotherapy knowledge. Prerequisite: Successful completion of all P-1 and P-2 level courses and P-3 Fall semester courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 522Toxicology and Poison Control

 Lec. 2./Credit 2. This course provides the basic concepts of toxicology. This course also serves to alert pharmacy students to commonly occurring exposures; to instruct students as to what symptoms are presented and the actions or recommendations to make in instances of acci- dental poisoning.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 523PPCP Skills Case Lab I Lec. 1./Lab 0. /Credit 1

This course will introduce the pharmacist’s patient care process (PPCP) to collect, assess, plan, implement, follow up and evaluate patient cases based on scenarios across a variety of clinical settings. Students will learn commu- nication abilities, how to collect a comprehensive patient history, develop an individualized patient-centered care plan in collaboration with other health care professionals, implement the care plan and conduct follow-up monitoring and evaluation using current, evidence-based guidelines and clinical trials. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 524PPCP Skills Case Lab II Lec. 1./Lab. 0. /Credit 1

This course will allow students to apply the knowledge related to Nutrition, GI and CNS and use the pharmacist’s patient care process (PPCP) to collect, assess, plan, implement, follow up and evaluate patient cases based on scenarios across a variety of clinical settings. Students will learn commu- nication abilities, how to collect a comprehensive patient history, develop an individualized patient-centered care plan in collaboration with other health care professionals, implement the care plan and conduct follow- up monitoring and evaluation using current, evidence-based guidelines and clinical trials. This course will continue to develop student knowledge by application of basic pharmaceutical and pharmacokinetic calculations where applicable. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 525Drug Information

& Health Informatics Lec. 2./Credit 2. Drug information and informatics will be the primary focus of this course. Principles of drug information, drug information retrieval and analysis, litera- ture evaluation, and verbal and written communication skills will be empha- sized. Students will be able to utilize the drug information skills learned in this course to provide optimal pharmaceutical care in any pharmacy practice setting. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 530Therapeutics I: Nutrition & GI Lec. 2./Credit 2

In this course, students will be provided a didactic framework for therapeutic management of selected Nutrition and GI disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharmacokinetics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process. This course will continue to develop student knowledge by application of basic pharmaceutical and pharmacokinetic calculations where applicable. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 531Therapeutics II: CNS Lec. 2./Credit 2

In this course, students will be provided a didactic framework for therapeutic management of selected CNS disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharmacoki- netics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process. This course will continue to develop student knowledge by application of basic pharmaceutical and pharmaco- kinetic calculations where applicable. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 532Pharmacy Law and Ethics Lec. 2./Credit 2

The basic principles of law are reviewed as they relate to the practice under federal, state, and local regulation. The special problems involving the control of narcotics, poisons, and other controlled substances are reviewed. Some laws relative to business activities and discussions of professional ethics are also included. Prerequisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 533Managed Health Care Lec. 2./Credit 2

This course is designed to introduce professional pharmacy stu- dents to the complexity of our health care delivery system and to provide fundamental information on management of pharma- ceuticals in various payer segments. Emphasis will be placed on understanding the key players in the health care system, the fun- damentals of formulary management, key issues that affect the pharmaceutical industry, and opportunities for pharmacists in man- aged care.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 534Pharmacogenomics Lec. 2./Credit 2

This course discusses how genes affect an individual’s response to drugs. An understanding of pharmacogenomics requires dual understanding of the basics of genetics and pharmacology. Students will learn how individual genetic information can be used to tailor drugs to patients to maximize efficacy and minimize adverse drug reactions. Topics that will be covered include: fundamentals of pharmacogenomics, interpretation of pharmacogenomic test results, literature evaluation and use of evidence-based guidelines, case based scenarios and implementation of pharmacogenomics in health care settings. Prerequisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 535Independent Study I Ind./Credit 2

The objectives of the course are to provide students with an opportunity to explore and analyze health care topics in depth. The exploratory aspect of the course requires students to perform and complete an independent project (of their choice with approval by the course coordinators) related to an admin- istrative principle, concept of trend that currently impacts the profession of pharmacy. The analytical aspect of the course requires students to participate in weekly briefings that will discuss traditional and controversial pharmacy administration issues. Prerequisite: Other majors: Approval of Department Chairperson; PharmD majors: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 536Independent Study II Ind./Credit 2

The objectives of the course are to provide students with an opportunity to explore and analyze health care topics in depth. The exploratory aspect of the course requires students to perform and complete an independent project (of their choice with approval by the course coordinators) related to an administrative principle, con- cept of trend that currently impacts the profession of pharmacy. The analytical aspect of the course requires students to participate in weekly briefings that will discuss traditional and controversial pharmacy administration issues. Students who complete PHA 535 must complete a different independent project for PHA 536.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 537IPPE I Lec. 1./Credit 1

This course is the first of six longitudinal IPPE (Introductory Pharmacy Practice Experience) and is designed to allow the student to gain experience with the various roles of pharmacists in the delivery of health care services in community pharmacy practice settings. Students will have the opportunity to observe and provide direct patient-oriented medication delivery and health care to a diverse patient population, and practice appropriate communica- tion with patients and members of the health care team. Through this super- vised experience, the student will be able to apply introductory concepts from clinical didactic course work to gain experience in direct patient care, promotion of wellness, and disease prevention. The pharmacy setting for this experience may include independent, chain, and health-system community sites. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 538IPPE II Lec. 1./Credit 1

This course is the second of six longitudinal IPPE (Introductory Pharmacy Practice Experience) and is designed to allow the student to gain experience with the various roles of pharmacists in the delivery of health care services in community pharmacy practice settings. Students will have the opportunity to observe and provide direct patient-oriented medication delivery and health care to a diverse patient population, and practice appropriate communica- tion with patients and members of the health care team. Through this super- vised experience, the student will be able to apply introductory concepts from clinical didactic course work to gain experience in direct patient care, promotion of wellness, and disease prevention. The pharmacy setting for this experience may include independent, chain, and health-system community sites. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 539Behavioral Psychology Lec. 2./Credit 2

The student is provided with an understanding of behavioral psychology and in particular the psychology of the chronically ill. The course attempts to improve the professionalism exhibited by students in their patient interac- tions and their associations with other members of the health care team.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 540Concentrated IPPE (Community) Lec. 1./Credit 1

This course is a three-week (120 hour) IPPE that students complete during the summer between their P1 and P2 years. Students are exposed to a commu- nity pharmacy setting in which they gain experience in the drug distribution process, patient counseling, and interprofessional collaboration. Students have opportunities to apply concepts and clinical knowledge from the P1 curriculum to patient care in the setting of a community pharmacy. They participate in patient care through communication with patients and other healthcare providers, the medication distribution process, patient counseling, and quality improvement processes. This course will continue to develop student knowledge by application of basic pharmaceutical and pharmacoki- netic calculations where applicable.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 541IPE & Professional Development I Lec. 1./Credit 1

This course is the first of six sequential courses that serve as an anchor for the co-curriculum and a home for tracking achievements of performance milestones. This course continues to expand on the 10 pharmacist attributes (problem solving/critical thinking, education, patient advocacy, cultural awareness, interprofessional collaboration, communication, self-awareness, leadership, innovation and entrepreneurship, and professionalism). This course focuses on development of leadership, self- awareness, profession- alism and innovative mindset. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 542IPE & Professional Development II Lec. 1./Credit 1

This course is the second of six sequential courses that serve as an anchor for the co-curriculum and a home for tracking achievements of performance milestones. This course continues to expand on the 10 pharmacist attributes (problem solving/critical thinking, education, patient advocacy, cultural awareness, interprofessional collaboration, communication, self-awareness, leadership, innovation and entrepreneurship, and professionalism). This course focuses on development of leadership, self- awareness, profession- alism and innovative mindset. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 545Healthcare Administration II Lec. 3./Credit 3

This course will provide the students pharmacy management principles that relate to contemporary pharmacy practice and present an introduction to the fundamentals of health outcomes research and pharmacoeconomic analysis. The overall goals of this course are to familiarize the student and provide basic tools in order to develop and deliver patient-centered pharmaceutical care services. Students will be exposed to pharmacoeconomic articles and partic- ipate in discussions which will provide them with tools useful to address the difficulties associated with implementing programs. Through an active learning process, students will follow and interpret current issues that are shaping pharmaceutical and medical care as they discover the impact these events will have in shaping their future practice. Prerequisites PHA 431.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 546Biopharmaceutics I

w/Lab Lec. 4./Lab. 0. /Credit 4. This course is designed to help students to understand physio-chemical and biological principles, which affect functions of various pharmaceutical dosage forms, including the solubility, acid base theory, pharmaceutical excipient, kinetics and drug stability, it will also focus on the design, preparation, evalu- ation and use of liquid and solid dosage forms. Calculations, metrology, basic prescription analysis, and laboratory exercises are also emphasized. Prereq- uisite: Admission to Doctor of Pharmacy program or approval of Department Chair. Course Descriptions – Main Campus 357

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 547Biopharmaceutics II & Basic

Pharmacokinetics w/Lab . . . . . . . . . . . . . . . . . -

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 548Pharmacology & Medicinal

Chemistry I Lec. 3./Credit 3. This is the first course in a five-part series. Students will explore basic concepts related to pharmacology, medicinal chemistry, and pharmacoge- nomics. An introduction to core principles of pharmacology will be discussed, a) mechanisms of action of drugs of various categories including biologics, b) basic pharmacodynamics and pharmacokinetics, c) adverse effects and side effects of drugs, d) mechanisms of drug‐drug interactions, e) drug discovery and development, f) acute and chronic toxic effect of xenobiotics, including drug and chemical overdose and antidotes, and g) pharmacogenomic and genetic basis of disease. Students will learn the medicinal chemistry of natural and synthetic drug entities, their physicochemical properties, sources, derivatives, modes of biotransformation, and structure activity relationships. Students will be able to link the chemical structure of drugs to their pharmacological/pharmacokinetic/toxicity profiles and apply them to making drug therapy decisions. Topics of focus include crude drugs from natural products and dietary supplements, general principles, autonomic nervous system (ANS), central nervous system (CNS), and gastrointestinal (GI) system medications. Prerequisite: Admission to Doctor of Pharmacy program or approval of Department Chair.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 561Analytical Methods

in the Pharmaceutical Sciences Lec 2./Credit 2 This course sequence is designed to provide the student the opportunity to learn various assay procedures and research methodologies in chemistry, pharmacology, chemotherapy, pharmaceutics and enzymology.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 562Clinical Pharmacokinetics Lec. 2./Credit 2

This course is designed to focus on strategies of developing and operating clinical pharmacokinetic or Therapeutic Drug Monitoring Services (TDMS). The course does not focus on manipulating pharmacokinetic equations to calculate drug dosages. It addresses the following areas: the environment in which the services are offered, the process involved in individualizing drug dosing, therapeutic/ pharmacodynamic monitoring and patient outcome assessment. The course will further address more detailed dosing concepts in special populations than provided in the foundation course in pharmaco- kinetics.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 563Introduction to Public Health

 Lec. 2./Credit 2. The objective of this elective course is to provide students with an understanding of the concepts and the importance of public health as a science and its goal of maximum health for all. Students will gain a thorough understanding of public health promotion and dis- ease prevention strategies especially relating to underserved, at- risk populations.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 564Advanced Dosage

Form Technology Lec. 2./Credit 2. This course will be concerned with the design, the technology, engineering principles and the biopharmaceutical aspects of non-sterile dosage forms. The course will guide the student from discovery of a new drug substance to the final delivery system. Initially the student will learn the physical-chemical information required by the industrial formulator, how it is collected and how it is used to decide on the final dosage forms.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 570Elective IPPE Credit 1

The elective introductory pharmacy practice experience (IPPE) is designed to expose students to additional areas of pharmacy practice. Elective opportunities are available in administration, association management, consulting, disease state management, geriatrics, home health, managed care, nuclear pharmacy, nutri- tion, oncology, pharmaceutical industry, regulatory affairs, and tox- icology. Other elective opportunities are available upon approval by the Director of Experiential Education. Prerequisites: Successful completion of all P-1, P-2 and P-3 level didactic courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 572Alternative and Complimentary

Medicine Lec. 2./Credit 2. This course is designed to provide the student with a basic knowledge about alternative practices used by patients as a self-medication option or in conjunction with physician ordered procedures in the United States as well as in other countries. The course’s approach is to present pharmacy students with the intellectual foundations and tools to understand the great diversity among different cultures in their self-medication practices. The student will be exposed to current information on herbs that are available in U.S. pharma- cies so they can offer counseling to patients on the. risks and benefits of using alternative medicine. Prerequisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 573Patient Assessment with Lab

 Lec. 1./Lab 1./Credit 2. This course is designed to develop knowledge in assessment, data collection, interpretation and evaluation of the patient physi- cal state. Additional techniques of patient interviewing, charting, medication profiling, and advisement will also be covered. Prereq- uisite: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 574Pharmacy Practice Lab Lab 4./Credit 4

This laboratory experience will simulate the actual practice of pharmacy in both retail and institutional settings. Students will learn the fundamentals of processing and filling a prescription or doctor’s drug order. He or she will gain experience in compounding medications, preparing sterile products, recom- mending over-the-counter medications, and counseling patients. Prerequi- site: Successful completion of all P-1, P-2 level courses, and P-3 Fall semester courses. Exceptions to this prerequisite policy will only be granted at the Dean’s discretion. Prerequisite: Successful completion of all P-1 and P-2 level courses ans P-3 Fall semester courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 576Nuclear Pharmacy Lec. 2./Credit 2

This course focuses on the study of radionuclides, their charac- teristics and detection, including the physics of radioactive decay, indepth study of the interaction of radiation with matter and the primary means of detection. Emphasis is placed on the radio- nuclides used in medicine. Mathematics, as it pertains to the mea- surement of radioactivity, and the phenomena decay are covered in detail. Radiation protection and health physics are discussed as they apply to the practice of nuclear pharmacy.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 577Natural Products Lec. 2./Credit 2

This course encompasses a study of drugs obtained from natural sources. The botanical and animal origins of such drugs, their historical importance, physiochemical properties, and their pharmacological applications are discussed. Basic terminology associated with the area of pharmacognosy as well as extraction and purification procedures for natural drugs are also discussed.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 582Drugs of Abuse Lec. 2./Credit 2

This course is designed to give the student a basic introduction to the area of substance abuse and dependency. It is intended that upon completion of this course the student will have an appreciation for the terminology and diagnostic criteria appropriate to this area. Prerequisite: BIO 224 OR BIO 336 and PHA 433 or 434; PharmD majors: Successful completion of all P-1 and P-2 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 587Health Disparities

and Service Learning Lec. 2./Credit 2. The Health Disparities course (PHA 587-01) is designed to introduce students to the concept of health disparities as defined in the United States by the National Institutes of Health and globally by the World Health Organization. This course will explore the historical factors leading to the lack of access to healthcare as well as to the variations in incidence and prevalence of diseases, and disabilities among different socioeconomic, racial, ethnic and/ or geographically defined population groups in the US. Furthermore, this course will address how the United States’ health inequities and inequali- ties impact the nation’s overall healthcare, political, societal, and economic systems. In addition, this course will introduce concepts of service learning, present strategies to improve health outcomes as well as provide information on private, federal and local programs which assist underserved populations. Prerequisites are not required for this course.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 590Pediatric Pharmacotherapy Lec. 2./Credit 2

The objective of the course is to present basic therapeutic principles and unique problems associated with pediatric drug therapy so that the students can more effectively participate in rational pediatric therapeutics. Hampton University 2026-2028

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 592Advance Nutritional/

Metabolic Support Lec. 2./Credit 2. In this course, the physiological theories of metabolic support in various disease states will be presented. This background information will be utilized by the students as they develop experience in assessing the patient’s metabolic status, estimating the patient’s nutritional requirements and formulating appropriate enteral or parenteral feedings.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 594Prescription Drug Therapy Review

Top 200 Drugs Lec. 2./Credit 2. This course involves the study of the top 200 most commonly prescribed drugs. Students will learn trade names, generic names, available strengths, available dosage forms, appropriate dosing guidelines, common adverse drug reactions, patient counseling information and clinically significant drug-drug interactions.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 595Clinical Oncology Lec. 2./Credit 2

This course provides an introduction to the pathology and treatment of neoplastic diseases with an emphasis on the patient and the application of clinical pharmacy concepts.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 597Geriatric Pharmacotherapy Lec. 2./Credit 2

This course will review the basic physiological changes occurring with increasing age and define their impact on pharmacokinetics of drugs in the geriatric patient. Managerial, pharmaceutical, and consultant aspects of pharmacy services provided to long term care facilities and alternate types of care available to the elderly patient will be emphasized. Health care issues impacting geriatric patient care and future trends in pharmacy services for geriatric patients will also be presented. Students will attend geriatric case study presentations of senior Pharm. D. students and participate in discussions to gain experience with therapeutic uses. Course Descriptions – Main Campus 365

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 601Pharmacy Practice Lab

& Patient Assessment I Lec. 2./Lab 0./Credit 2 . This laboratory course will simulate the actual practice of pharmacy in community settings. Students will learn the fundamentals of processing and adjudication of prescriptions using technology used in the commu- nity pharmacy setting, and workflow. Students will gain experience in compounding nonsterile medications and products, recommending over-the- counter medications, and patient counseling. Additionally, this course will develop knowledge and skills in pharmacist patient assessment techniques. Students will learn to perform basic patient subjective and objective assess- ment related to provision of patient care, including patient interviewing, obtaining medical history, vital signs assessment, and point-of-care testing.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
Prerequisite
Successful completion of all P-1 level courses.
PHA 602Pharmacy Practice Lab

& Patient Assessment II Lec. 2./Lab 0./Credit 2. This course introduces students to the knowledge, skill set, and resources needed to practice in an institutional setting. Contextualized, competency- based, learning activities are used to develop the knowledge and skills in pharmacist patient assessment techniques related to provision of patient care, including patient interviewing, obtaining medical history from the EHR and patient, vital signs assessment, and point-of-care testing. Prerequisites Successful completion: of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 620Healthcare Administration I Lec. 2./Credit 2

This course focuses on the structure and organization, delivery, regulation (Medicare, Medicaid, & Medicaid Expansion, Managed Care), and financing of the American healthcare system. Pharmacy, its role and responsibilities in the healthcare system, public health, and its interaction with other health occupations is discussed. Reimbursement issues in healthcare are introduced and implications upon the practice of health care are discussed. This course covers the functions of management and administration (planning, organiza- tion, staffing, direction, and controlling) applied to pharmacy practice in the community and institutional settings. Contemporary management principles for the solution of these problems are discussed, in addition to introduc- tion to basic management principles and methods; entrepreneurial, social and pharmacoeconomic aspects and their effect on practice. Prerequisites: Successful completion of all P-1 level courses. Hampton University 2026-2028

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 623PPCP Skills Case Lab III Lec. 1./Credit 1

In this course, students will apply the knowledge related to cardiovascular, renal and pulmonary disorders and use the pharmacist’s patient care process (PPCP) to collect, assess, plan, implement, follow up and evaluate patient cases based on scenarios across a variety of clinical settings. Students will learn communication abilities, how to collect a comprehensive patient history, develop an individualized patient-centered care plan in collaboration with other health care professionals, implement the care plan and conduct follow-up monitoring and evaluation using current, evidence-based guide- lines and clinical trials. Prerequisites :Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 624PPCP Skills Case Lab IV1
Subject
PHA
Credits (min)
1
Credits (max)
1
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 625Biostatistics and Clinical

Research Methods Lec. 3./Credit 3 . This course introduces students to the basic concepts of biostatistics and research. Basic concepts will include understanding and developing the research question, hypothesis testing, methodology, data collection and analysis, results, and conclusion. Students will analyze a secondary dataset, perform spatial analysis, write an abstract and prepare a presentation utilizing a 10-step plan that encompasses these basic principles. The presentation will be presented at the end of the semester. Students will also gain experience developing scientific posters to present findings of research studies. Prereq- uisites :Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 630Therapeutics III: Cardiovascular Lec. 4./Credit 4

In this course, students will be provided a didactic framework for therapeutic management of selected cardiovascular disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharmacokinetics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process: Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 631Therapeutics IV: Renal 2

1st 2nd PHA 632 Therapeutics V: Pulmonary . . . . . . . . . . . . . 2 - - Elective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 - - PHA 623 PPCP Skills Case Lab III . . . . . . . . . . . . . . . . 1 - - PHA 637 IPPE III . . . . . . . . . . . . . . . . . . . . . . . . . . 1 - . . . 2 - PHA 641 IPE & Professional Development II . . . . . . . . . 1 - - PHA 648 Pharmacology & Medicinal Chemistry III . . . . . - 3 - PHA 602 Pharmacy Practice Lab & Patient Assessment II - 2 4 PHA 620 Healthcare Administration I . . . . . . . . . . . . . - 2 2 PHA 625 Biostatistics and Clinical Research Methods . . - 3 3 PHA 633 Therapeutics VI: Endocrine . . . . . . . . . . . . . - 2 1 PHA 634 Therapeutics VII: Women’s & Men’s Health . . . . - 1 3 PHA 635 Therapeutics VII: Rheumatology & Pain . . . . . . - 2 Hampton University 2026-2028

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 632Therapeutics V: Pulmonary2

Elective Elective . . . . . . . . . . . . . . . . . . . . . . . . . . 2

Subject
PHA
Credits (min)
2
Credits (max)
2
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 633Therapeutics VI: Endocrine Lec. 2./Credit 2

In this course, students will be provided a didactic framework for therapeutic management of selected endrocine disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharma- cokinetics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process. Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 634Therapeutics VII

Women and Men’s Health Lec. 2./Credit 2. In this course, students will be provided a didactic framework for therapeutic management of selected women’s and men’s health disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharmacokinetics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process. Prerequisites: Successful completion of all P-1 level courses. Course Descriptions – Main Campus 359

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 635Therapeutics VIII

Rheumatology Lec. 2./Credit 2 . In this course, students will be provided a didactic framework for therapeutic management of selected rheumatology and pain disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharmacokinetics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process. Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 637IPPE III Lec. 1./Credit 1

This early practice Experience is designed to facilitate successful interaction with the elderly population and their social support network on personal and professional levels through discussion of physiologic changes and normal and pathologic aging; important medical conditions most common among the elderly; the impact of chronic illness; issues in death and dying; modifica- tions in drug therapy; and the role of the pharmacist in caring for the elderly.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
Prerequisite
Successful completion of all P-1 level courses.
PHA 638IPPE IV Lec. 1./Credit 1

This early practice experience will introduce pharmacy students to the funda- mentals of pharmacy practice in the hospital setting. To complement their didactic curriculum, experiential experiences allow them to see pharmacy in action. The IPPE should be their opportunity to focus on the distributive and operational side of hospital pharmacy. Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 640Concentrated IPPE II (Institutional)1

Third Professional Year Semester 1st 2nd

Subject
PHA
Credits (min)
1
Credits (max)
1
Credit unit
credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 641IPE & Professional

Development III Lec. 1./Credit 1. This course is the third of six sequential courses that serve as an anchor for the co-curriculum and a home for tracking achievements of performance milestones. This course continues to expand on the 10 pharmacist attributes (problem solving/critical thinking, education, patient advocacy, cultural awareness, interprofessional collaboration, communication, self-awareness, leadership, innovation and entrepreneurship, and professionalism). This course focuses on development of leadership, self- awareness, profession- alism and innovative mindset. Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 642IPE & Professional Development IV1

TOTAL 18 18 Summer Semester . . . . . . . . . . . . . . . . . . . . . . . .

Subject
PHA
Credits (min)
1
Credits (max)
1
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 647Pharmacology &

Medicinal Chemistry II Lec. 3./Credit 3. This is the second course in a five-part series. Students will explore basic concepts related to pharmacology, medicinal chemistry, and pharmacoge- nomics. An introduction to core principles of pharmacology will be discussed, a) mechanisms of action of drugs of various categories including biologics, b) basic pharmacodynamics and pharmacokinetics, c) adverse effects and side effects of drugs, d) mechanisms of drug‐drug interactions, e) drug discovery and development, f) acute and chronic toxic effect of xenobiotics, including drug and chemical overdose and antidotes, and g) pharmacogenomic and genetic basis of disease. Students will learn the medicinal chemistry of natural and synthetic drug entities, their physicochemical properties, sources, derivatives, modes of biotransformation, and structure activity relationships. Students will be able to link the chemical structure of drugs to their pharmacological/pharmacokinetic/toxicity profiles and apply them to making drug therapy decisions. Topics of focus include cardiovascular system, renal system, and pulmonary system medications. Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 648Pharmacology &

Medicinal Chemistry III Lec. 3./Credit 3 . This is the third course in a five-part series. Students will explore basic concepts related to pharmacology, medicinal chemistry, and pharmacoge- nomics. An introduction to core principles of pharmacology will be discussed, a) mechanisms of action of drugs of various categories including biologics, b) basic pharmacodynamics and pharmacokinetics, c) adverse effects and side effects of drugs, d) mechanisms of drug‐drug interactions, e) drug discovery and development, f) acute and chronic toxic effect of xenobiotics, including drug and chemical overdose and antidotes, and g) pharmacogenomic and genetic basis of disease. Students will learn the medicinal chemistry of natural and synthetic drug entities, their physicochemical properties, sources, derivatives, modes of biotransformation, and structure activity relationships. Students will be able to link the chemical structure of drugs to their pharma- cological/pharmacokinetic/toxicity profiles and apply them to making drug therapy decisions. Topics of focus include endocrine/reproductive systems, rheumatic, and pain medications. Prerequisites: Successful completion of all P-1 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 650651, 652 Seminar I, II, III Sem. 1./Credit 1

The Seminar Series is a three course requirement that is designed to provide students with the skills, techniques, and competen- cies required to successfully navigate the advanced clinical clerk- ship experiences. In addition this course provides the student an opportunity and experience in preparing and presenting pharmacy related topics to colleagues and other healthcare professionals in a formalized manner. Prerequisites: Successful completion of all P-1, P-2, and P-3 courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 670Community Pharmacy

Practice Experience (APPE) Credit 4. An advanced pharmacy practice experience designed to assist the student in actively participating and experiencing the distributive functions of pharmacy in the community pharmacy practice setting. The community pharmacy practice setting experience is divided into six main areas of experience: prescription processing and compounding, over the counter products, patient counseling and education, pharmacy administration and management, pharmacy law, and team interaction/education. Prerequisite: Successful completion of P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 671Institutional Pharmacy Practice

Experience (APPE) Credit 4. An advanced pharmacy practice experience designed to assist the student in actively participating and experiencing the distributive functions of pharmacy in the institutional pharmacy practice set- tings. The institutional pharmacy practice experience is divided into seven main areas of experience: drug distribution, manufac- turing activities, dissemination of drug and product information, patient counseling and education, pharmacy administration and management, pharmacy law, and team interaction/education. Pre-

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
Prerequisite
Successful completion of P-3 level courses.
PHA 672Community/Institutional Pharmacy

Practice Experience (APPE) II Credit 4. An advanced pharmacy practice experience designed to assist the student in actively participating and experiencing the distributive functions of pharmacy in the community, institutional, or other pharmacy practice settings, which provide distributive services of pharmaceuticals (nuclear pharmacy, long- term care, mail order, etc.). The pharmacy practice experience is designed to provide additional experience in the following areas: prescription processing and compounding, over the counter medications, drug distribution, manufac- turing management, pharmacy law, and team interaction/ education. Prereq- uisite: Successful completion of P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 683Geriatrics Credit 4

This course focuses on inpatient and/or outpatient experiences in the care of the elderly. Objectives will include developing medication care plans (MCP) for patients who have diminished blood flow in concert with multiple disease states, frailty of body and spirit, diminished mental capacity, diminished mobility, and reduction in use of senses (e.g. sight, hearing). Attention will also be focused on developing the most economical MCP for persons with reduced or limited income. Simultaneous assignment to several inpatient facilities, home health care agencies, or home bound patients is likely. An understanding of the impact of Medicare and other insurance plans on the ability to deliver the best MCP is an objective for all assignment areas. Prereq- uisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 684Special Interest APPE Credit 4

The elective rotation is designed to expose students to additional areas of pharmacy practice of their interest. Elective opportunities are available in administration, association management, consulting, disease state manage- ment, geriatrics, home health, managed care, nuclear, nutrition, oncology, pharmaceutical industry, regulatory affairs, and toxicology. Other elective opportunities are available upon approval by the Director of Experiential Education. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 685Administration/Management Credit 4

This course is designed to expose the student to a variety of situations related to the running of a medical-related operation, including medical profession associations. The student will be paired with an administrative level preceptor from industry, chain pharmacy, hospital pharmacy, or professional organi- zation. The five week rotation may be split among as many as three such experiences with no less than one week in any specific arena. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 690Internal Medicine I Credit 4

The Internal Medicine I advanced pharmacy practice experience is designed to provide the student exposure and experience in comprehensive treatment of disease states of adult patients being cared for in an institutionalized setting. In addition, students will utilize problem-solving skills, develop therapeutic plans, monitor lab values, and assess for drug interactions and adverse drug reac- tions. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 691Ambulatory Care I Credit 4

The Ambulatory Care I advanced pharmacy practice experience is designed to give students experience in treating patients who are typically not acutely ill in “out-patient” settings. These experiences could focus on the medication management of specific diseases (such as hypertension, diabetes, asthma, hyperlipidemia, etc.) or general care of patients with chronic conditions. Students will be involved in problem solving, patient medication counseling and ther- apeutic monitoring. In addition, they will address drug interactions, side effects, and compliance issues in the care of these patients.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
Prerequisite
Successful completion of all P-3 level courses.
PHA 692Ambulatory Care II Credit 4

The Ambulatory Care II advanced pharmacy practice experience will focus on management of patients in specialized out-patient settings such as retail pharmacy, managed care, long-term care, home health care, and specialty clinics or programs. Prerequisites: Successful completion of all P-3 level courses. Hampton University 2018-2020

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 693Pediatrics Credit 4

The pediatric advanced pharmacy practice experience provides students with the opportunity to learn how to effectively treat medical illnesses of infant and child patients. Students will learn the different treatment options and regimens utilized in this patient population and take into consideration the different pharmacokinetic profiles of drugs in infants and children. Common disease states that will be seen are pneumonia, asthma, epilepsy, diabetes, sickle cell, trauma, and other common childhood diseases. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 694Psychiatry Credit 4

The psychiatric advanced pharmacy practice experience provides students experience in treating acute as well as chronic psychiatric patients. Emphasis is on the initiation of medication, therapeutic monitoring, as well as medica- tion stabilization and long-term treatment of psychiatric patients. Students will learn how to dose, treat, and monitor patients with mood disorders, schizophrenia, substance abuse disorders, cognitive disorders and other clinical psychiatric disorders. Prerequisites: Successful completion of all P-3 level courses. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 695Drug Information Credit 4

This clerkship experience allows the student to serve as a primary provider of drug information in a structured environment that possesses both the resources and the faculty expertise in clinical information management and dissemination. Emphasis is placed on how to properly receive drug informa- tion requests, design and execute a systematic search strategy, assimilate the information retrieved, and formulate and communicate an appropriate response. The student continues to build their knowledge base of avail- able drug information resources and gains practical experience in critically evaluating those resources. Students also prepare drug monographs and journal articles to further develop their medical writing skills. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 696Elective I Credit 4

The elective rotation is designed to expose students to additional areas of pharmacy practice of their interest. Elective opportunities are available in administration, association management, consult- ing, disease state management, geriatrics, home health, managed care, nuclear, nutrition, oncology, pharmaceutical industry, regula- tory affairs, and toxicology. Other elective opportunities are avail- able upon approval by the Director of Experiential Education. Pre-

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
Prerequisite
Successful completion of all P-3 level courses.
PHA 697Special Interest APPE Credit 4

The elective rotation is designed to expose students to additional areas of pharmacy practice of their interest. Elective opportunities are available in administration, association management, consulting, disease state manage- ment, geriatrics, home health, managed care, nuclear, nutrition, oncology, - pharmaceutical industry, regulatory affairs, and toxicology. Other elective opportunities are available upon approval by the Director of Experiential Education. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 698Special Interest APPE Credit 4

The elective rotation is designed to expose students to additional areas of pharmacy practice of their interest. Elective opportunities are available in administration, association management, consulting, disease state manage- ment, geriatrics, home health, managed care, nuclear, nutrition, oncology, pharmaceutical industry, regulatory affairs, and toxicology. Other elective opportunities are available upon approval by the Director of Experiential Education. Prerequisites: Successful completion of all P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 699Internal Medicine II Credit 4

The Internal Medicine II advanced pharmacy practice experience is designed to provide the student exposure and experience in comprehensive treatment of disease states of adult patients being cared for in an institutionalized setting. In addition, students will utilize problem-solving skills, develop therapeutic plans, monitor lab values, and assess for drug interactions and adverse drug reac- tions. Furthermore, students will be exposed to specialized internal medicine areas, such as hematology/oncology, ICU, CCU, surgery, general oncology and infectious diseases. Prerequisites: Success- ful completion of all P-3 level courses. Hampton University 2018-2020

Subject
PHA
Type
course
Edition
2026
Source
img2.hamptonu.edu
PHA 701Population & Public Health Lec. 2./Credit 2

This course will cover pertinent topics related to both population and public health. Population health is concerned with the overall health outcomes and factors that affect a group of individuals, while public health focuses on preventing and controlling diseases and promoting healthy lifestyles through coordinated efforts of various stakeholders. Students will understand how the social determinants of health relate to both population and public health. Students will use the social-ecological model as a framework to understand how various factors in a person’s environment interact to influence their health behaviors and outcomes. They will also use the model to design inter- ventions that address those multiple levels of influence to promote positive health behaviors and outcomes on specific public health topics. Prerequi- sites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 702Healthcare Equity & Service Learning2

2nd PHA 724 PPCP Skills Case Lab VI . . . . . . . . . . . . . . . . - 1 - PHA 738 IPPE VI . . . . . . . . . . . . . . . . . . . . . . . . . . - 1 - PHA 742 IPE & Professional Development VI . . . . . . . . . - 1 - Elective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - 2 - TOTAL 18 17 - Fourth Professional Year Credit - PHA 800 Seminar I . . . . . . . . . . . . . . . . . . . . . . . . 1 - PHA 803 APPE I . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 - PHA 804 APPE II . . . . . . . . . . . . . . . . . . . . . . . . . . 4 3 PHA 801 Seminar II . . . . . . . . . . . . . . . . . . . . . . . . 1 2 PHA 802 Seminar III . . . . . . . . . . . . . . . . . . . . . . . . 1

Subject
PHA
Credits (min)
2
Credits (max)
2
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 703Personalized Drug

Therapy Management Lec. 2./Credit 2. This course will provide the key knowledge and tools to understand the funda- mentals and practical implications of precision medicine, its opportunities and challenges. It will address precision-medicine era diagnostics, treatment selection, genetic counseling, pharmacogenomics, public health interven- tions, and biomedical research. It will also address data science and ethical issues. Prerequisites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 704Pharmacy Practice Lab

& Patient Assessment III Lec. 2./Lab 0./Credit 2. This course introduces students to the knowledge, skill set, and resources needed to practice in a community and ambulatory care setting and clinical pharmacokinetics. Contextualized, competency-based, learning activities are used to develop the knowledge and skills in pharmacist patient assessment techniques related to provision of patient care, including patient interviewing, obtaining medical history from the EHR and patient, vital signs assessment, and point-of-care testing. Prerequisites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 706Pharmacy Law & Ethics Lec. 2./Credit 2

The purpose of this course is to reinforce principles of law and ethics in pharmacy with a focus on those laws and ethical situations that are most encountered in a community pharmacy practice setting. The course will examine the federal and Virginia state laws that impact the practice of pharmacy, while emphasizing the legal and ethical principles applied by pharmacists in their daily decision-making. Students will learn the govern- mental framework within which pharmacy is practiced, as well as acquire an understanding of the laws, regulations, and the ethical responsibilities applicable to pharmacists so that they will be able to protect the public and ensure patients’ well-being Prerequisites: Successful completion of all P-1 and P-2 level courses 362 Course Descriptions – Main Campus

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 720Healthcare Administration II Lec. 2./Credit 2

This course will introduce students to pharmacy management principles that relate to contemporary pharmacy practice and present an introduction to the fundamentals of health outcomes research and pharmacoeconomic analysis. The overall goals of this course are to familiarize the student and provide basic tools in order to develop and deliver patient-centered pharmaceutical care services. Students will be exposed to pharmacoeconomic articles and partici- pate in discussions which will provide them with the tools useful to address the difficulties associated with implementing community and hospital based programs. Through an active learning process, students will follow and inter- pret current issues that are shaping pharmaceutical and medical care as they discover the impact these events will have on their future practice. Prerequi- sites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 723PPCP Skills Case Lab V Lec. 1./Credit 1

In this course, students will apply the knowledge related to hematology, oncology and special populations and use the pharmacist’s patient care process (PPCP) to collect, assess, plan, implement, follow up and evaluate patient cases based on scenarios across a variety of clinical settings. Students will learn communication abilities, how to collect a comprehen- sive patient history, develop an individualized patient-centered care plan in collaboration with other health care professionals, implement the care plan and conduct follow-up monitoring and evaluation using current, evidence- based guidelines and clinical trials. Prerequisites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 724PPCP Skills Case Lab VI Lec. 1./Credit 1

In this course, students will apply the knowledge related to clinical microbi- ology, immunology & infectious disease disorders and use the pharmacist’s patient care process (PPCP) to collect, assess, plan, implement, follow up and evaluate patient cases based on scenarios across a variety of clinical settings. Students will learn communication abilities, how to collect a comprehen- sive patient history, develop an individualized patient-centered care plan in collaboration with other health care professionals, implement the care plan and conduct follow-up monitoring and evaluation using current, evidence- based guidelines and clinical trials. Prerequisites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 730Therapeutics IX: Hematology

& Oncology Lec. 3./Credit 3 . In this course, students will be provided a didactic framework for therapeutic management of selected hematology and oncology disorders. The course will reinforce and ensure competency in pathophysiology, pharmacology and clinical pharmacokinetics. The goal of this course is to prepare students to develop rational drug therapy plans using the PPCP process. Prerequisites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 731Therapeutics X: Special Populations 2

Elective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 -

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 732Therapeutics XI: Clinical Microbiology

& Infectious Disease . . . . . . . . . . . . . . . . . . . . - 4

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 737IPPE V Lec. 1./Credit 1

In this early practice experience, students work with other healthcare providers and/or their students to learn about IPE competencies in the ambulatory care practice setting with a focus on roles/responsibilities, teams/teamwork, and interprofessional communication. In addition to the interactions that occur in the clinical setting, there is one intentional IPE activity where students from pharmacy and medicine will collaborate on a case-based problem as a means of introducing them to the roles/responsibilities and communication with the other discipline. Prerequisites: Successful completion of all P-1and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 738IPPE VI Lec. 1./Credit 1

In this early practice experience, students work with other healthcare providers and/or their students to reinforce IPE competencies in the hospital/ health system practice setting as they perform medication reconciliation. The focus is on roles/responsibilities, teams/teamwork, and interprofessional communication. Prerequisites: Successful completion of all P1 andP-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 741IPE & Professional Development V1

Elective Elective . . . . . . . . . . . . . . . . . . . . . . . . . . 2

Subject
PHA
Credits (min)
1
Credits (max)
1
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 742IPE & Professional Development VI1

Elective . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - 2 TOTAL 18 17

Subject
PHA
Credits (min)
1
Credits (max)
1
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 747Pharmacology &

Medicinal Chemistry IV Lec. 2./Credit 2 . This is the fourth course in a five-part series. Students will explore basic concepts related to pharmacology, medicinal chemistry, and pharmacoge- nomics. An introduction to core principles of pharmacology will be discussed, a) mechanisms of action of drugs of various categories including biologics, b) basic pharmacodynamics and pharmacokinetics, c) adverse effects and side effects of drugs, d) mechanisms of drug‐drug interactions, e) drug discovery and development, f) acute and chronic toxic effect of xenobiotics, including drug and chemical overdose and antidotes, and g) pharmacogenomic and genetic basis of disease. Students will learn the medicinal chemistry of natural and synthetic drug entities, their physicochemical properties, sources, derivatives, modes of biotransformation, and structure activity relationships. Students will be able to link the chemical structure of drugs to their pharmacological/pharmacokinetic/toxicity profiles and apply them to making drug therapy decisions. Topics of focus include general principles of special populations, hematology, and oncology medications. Prerequisites: Successful completion of all P-1 and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 748Pharmacology & Medicinal Chemistry V2

156 School of Pharmacy

Subject
PHA
Credits (min)
2
Credits (max)
2
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 778Pharmacology &

Medicinal Chemistry V Lec. 2./Credit 2. This is the fifth course in a five-part series. Students will explore basic concepts related to pharmacology, medicinal chemistry, and pharmacoge- nomics. An introduction to core principles of pharmacology will be discussed, a) mechanisms of action of drugs of various categories including biologics, b) basic pharmacodynamics and pharmacokinetics, c) adverse effects and side effects of drugs, d) mechanisms of drug‐drug interactions, e) drug discovery and development, f) acute and chronic toxic effect of xenobiotics, including drug and chemical overdose and antidotes, and g) pharmacogenomic and genetic basis of disease. Students will learn the medicinal chemistry of natural and synthetic drug entities, their physicochemical properties, sources, derivatives, modes of biotransformation, and structure activity relationships. Students will be able to link the chemical structure of drugs to their pharma- cological/pharmacokinetic/toxicity profiles and apply them to making drug therapy decisions. Topics of focus include antimicrobials, immunology, and infectious diseases medications. Prerequisites: Successful completion of all P-1and P-2 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 800Seminar I1

TOTAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 credits Fourth Professional Year Semester 1st 2nd APPE III . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 - APPE IV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 - APPE V . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 -

Subject
PHA
Credits (min)
1
Credits (max)
1
Credit unit
credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 801Seminar II 1

APPE VI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - 4 APPE VII . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - 4 APPE VIII . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . - 4

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 802Seminar III1

TOTAL 13 13 TOTAL CREDIT HOURS 144

Subject
PHA
Credits (min)
1
Credits (max)
1
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 803Advanced Community

Pharmacy Lec. 4./Credit 4. The course is required Advance Community Pharmacy APPE and is 5 weeks (200 hours). This course provides students with experience in community pharmacy setting. Students will focus efforts on developing abilities to provide patient-centered pharmacy care services and patient focused dispensing services. Student activities should include many of the following: disease state management, medication therapy management (MTM), preventative health screening(s), providing and documenting immunizations, specialty compounding, and patient education/counselling, or other advanced patient care activities. Students will actively participate in activities such as health- care provider interactions, patient and caregiver interactions, and OTC/ Self-Care interactions and recommendations. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses Course Descriptions – Main Campus 363

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 804Advanced Institutional Pharmacy

(Hospital Practice) Lec. 4./Credit 4 . The course is required Advanced Institutional Pharmacy Practice Experience (APPE) and is 5 weeks (200 hours). This course provides students with experi- ence in an approved health system that prepares the student to function within a hospital or health-system of integrated pharmacy services. Emphasis is placed on the preparation, distribution, and control of medications, medica- tion monitoring, and the ability to communicate with other healthcare profes- sionals, and the ability to work in a team. This rotation focuses on competence to practice in a hospital staffing position. It integrates problem-solving and clinical skills with the basics of inpatient medication distribution, monitoring, and control. The student is expected to demonstrate they are able to practice satisfactorily in this environment. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 805APPE III4

4 PHA 806 APPE IV . . . . . . . . . . . . . . . . . . . . . . . . . . 4 2 [Refer to Catalog] APPE V . . . . . . . . . . . . . . . . . . . . 4 2 [Refer to Catalog] APPE VI . . . . . . . . . . . . . . . . . . . . 4 1 [Refer to Catalog] APPE VII . . . . . . . . . . . . . . . . . . . 4 1 [Refer to Catalog] APPE VIII . . . . . . . . . . . . . . . . . . . 4 1 TOTAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 credits 18 MINORS IN THE SCHOOL 2nd OF PHARMACY - Minors in the School of Pharmacy are open to all majors - who meet the prerequisite requirements. - • Minors in the School of Pharmacy are open to all - majors who meet the prerequisite requirements. - - • All minors are 18 – 19 credit hours. - • Students must maintain at least a “C” average (2.0 - overall GPA) to remain in the school for the minor. - • Students must earn at least a “C” in all minor courses. 3 MINOR IN ENVIRONMENTAL HEALTH SCIENCES 2 The Environmental Health Sciences minor requires 2 19 credit hours. Seventeen (17) credit hours must be 3 completed from the list of required core courses with a 2 minimum of 2 credit hours from the list of electives. 2 Required Core Courses (17 credit hours from the following list) 1 PHS 518 Biostatistics and Research Methods . . . . . . . . . 3 1 PHA 420 Principles of Toxicology . . . . . . . . . . . . . . . . . 2 18 PHM 402 Foundations of Public Health . . . . . . . . . . . . . 3 2nd EHS 401 Principles of Environmental Health Sciences – I . . 3 - EHS 402 Principles of Environmental Health Sciences – II . 3 - EHS 403 Environmental Microbiology & Vector-Borne - Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 3 - Electives (Minimum of 2 credit hours from the following list) - Credit - PHS 587 Introduction to Health Disparities . . . . . . . . . 2 - CHE 509 Environmental Chemistry . . . . . . . . . . . . . . . 3 - MES 510 Environmental Toxicology . . . . . . . . . . . . . . . 3 - PHS 300 Quantitative Lab Techniques . . . . . . . . . . . . . 2 - TOTAL CREDIT HOURS 19 Hampton University 2026-2028

Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 806Internal Medicine Lec. 4./Credit 4

The course is an Advanced Inpatient Clinical Skills APPE and is 5 weeks (200 hours). This course provides students with experience in a clinical, acute care institutional, team-based environment. Students will be expected to utilize abilities learned throughout the pharmacy curriculum in order achieve the goals of the rotation. These tasks include collecting patient-specific informa- tion, evaluating and monitoring drug therapy, educating patients or caregivers, responding to drug information inquiries, and functioning effectively within a health care team. Learning will be accomplished through a variety of ways including but not limited to team rounding, written projects, oral presenta- tions, and other pharmacy related tasks. Prerequisites: Successful Comple- tion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 807Drug Information Lec. 4./Credit 4

The course is an elective Drug Information APPE and is 5 weeks (200 hours). This course enables students to demonstrate a systematic approach to drug information inquiries. Students will apply knowledge, skills, and abilities devel- oped throughout the curriculum to respond to drug information questions by researching and evaluating relevant literature, applying research results to questions, and communicating appropriate answers to the inquirer(s) under the supervision of a preceptor. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 808Geriatrics Elective Lec. 4./Credit 4

The course is an elective Geriatrics APPE and is 5 weeks (200 hours). This course focuses on the provision of clinical pharmacy services in a variety of settings with a focus on care for the elderly population. These sites may include community pharmacies, specialty clinics, rehabilitation hospi- tals, skilled nursing facilities (SNFs), home-based consult services, senior independent living, and assisted living facilities (ALFs). A focus is placed on the interdisciplinary care of the geriatric population. Student pharmacists will enhance knowledge of how to assess pharmacotherapy and appropriateness of drugs, determine how safely and effectively a patient can self-administer the therapy, and how to implement plans to ensure such safe and effective use. Students will be expected to utilize, refine, and apply their knowledge base of pharmacology, pharmacokinetics, pathophysiology, and therapeutics to enhance the quality of pharmaceutical care of the elderly. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses PHA 809,810,811,812 Special Interest Electives Lec. 4./Credit 4. The Special Interest Electives are advanced experience ( 5 weeks/ 200 hours) provides distinctive options for students to participate in areas such as compounding, nuclear pharmacy, academia, research, consulting, industry and other environments where patient care is not the primary focus. Specialty areas will vary according to preceptor and site availability. Students will apply knowledge, skills, and abilities developed throughout the curriculum to course and site-specific objectives and will demonstrate effective verbal and written communication skills in fulfillment of their responsibilities. Prerequi- sites: Successful completion of all P-1, P-2, and P-3 level courses

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 870Advanced Community Pharmacy4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 871Advance Institutional Pharmacy

(Hospital Practice) APPE . . . . . . . . . . . . . . . 4

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 873Nuclear Pharmacy APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 874Compounding APPE Lec. 4./Credit4

This elective rotation is designed to enhance the basic skills of compounding. Skills that will be developed and refined in this rotation include basic and advance compounding, pharmacy math, patient counseling on unique drug formulations, determining the correct ratio of hormone product for hormone replacement therapy. This rotation might also include skills developed in a community pharmacy setting such as the ability to process and dispense medication, and patient education regarding medical conditions. Prerequi- sites: Successful completion of all P-1, P-2, and P-3 level courses 364 Course Descriptions – Main Campus

Subject
PHA
Credits (min)
4
Credits (max)
4
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 875Academic

Pharmacy APPE Lec. 4./Credit 4 Lec. 4./Credit 4 This elective rotation is designed to enhance the student’s awareness of a career in academia. The experience will allow the student to develop a teaching style that complements their style and strengths, and expose the student to the wide range of responsibilities associated with a didactic based academic career. The student will be given a firsthand experience in the academic responsibility of teaching, scholarship, and service to the pharmacy profession and the academic institution. Prerequisites: Successful comple- tion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 876Managed Care APPE4

Hampton University 2026-2028

Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 880Research I APPE Lec. 4./Credit4

This elective rotation is intended to provide an opportunity for Doctor of Pharmacy students to acquire experience in the various aspects of research of discovery, integration, application or teaching. The rotation is a five-week experience in which the student will participate in a collaborative research process with faculty from the department of pharmacy practice and/ or pharmaceutical sciences. Give the time limit, the intent is to expose the student to techniques and behavioral skills for identifying research questions or problems, performing literature searches, defining discipline-related termi- nology, demonstrating the development of lab techniques, patient care or teaching skills, and reflecting on lesson learned on conducting biomedical, clinical and translational research. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Credits (min)
4
Credits (max)
4
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 881Research II APPE Lec. 4./Credit4

This elective rotation is intended to provide an opportunity for Doctor of Pharmacy students to acquire experience in the various aspects of research of discovery, integration, application or teaching. The rotation is a five-week experience in which the student will participate in a collaborative research process with faculty from the department of pharmacy practice and/ or pharmaceutical sciences. Give the time limit, the intent is to expose the student to techniques and behavioral skills for identifying research questions or problems, performing literature searches, defining discipline-related termi- nology, demonstrating the development of lab techniques, patient care or teaching skills, and reflecting on lesson learned on conducting biomedical, clinical and translational research. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Credits (min)
4
Credits (max)
4
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 883Geriatrics APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 884Special Interest APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 885Administration/

Management APPE Lec. 4./Credit 4 This course is designed to expose the student to a variety of situations related to the running of a medical-related operation, including medical profession associations. The student will be paired with an administrative level preceptor from industry, chain pharmacy, hospital pharmacy, or professional organi- zation. The five week rotation may be split among as many as three such experiences with no less than one week in any specific arena. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 890Internal Medicine4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 891Ambulatory Care4

ELECTIVES (Choose 4)

Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 892Ambulatory Care II APPE Lec. 4./Credit4

The Ambulatory Care II advanced pharmacy practice experience will focus on management of patients in specialized out-patient settings such as retail pharmacy, managed care, long-term care, home health care, and specialty clinics or programs. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses. Hampton University 2026-2028

Subject
PHA
Credits (min)
4
Credits (max)
4
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 893Pediatrics APPE Lec. 4./Credit4

The pediatric advanced pharmacy practice experience provides students with the opportunity to learn how to effectively treat medical illnesses of infant and child patients. Students will learn the different treatment options and regimens utilized in this patient population and take into consideration the different pharmacokinetic profiles of drugs in infants and children. Common disease states that will be seen are pneumonia, asthma, epilepsy, diabetes, sickle cell, trauma, and other common childhood diseases. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Credits (min)
4
Credits (max)
4
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 894Psychiatry APPE Lec. 4./Credit4

The psychiatric advanced pharmacy practice experience provides students experience in treating acute as well as chronic psychiatric patients. Emphasis is on the initiation of medication, therapeutic monitoring, as well as medica- tion stabilization and long-term treatment of psychiatric patients. Students will learn how to dose, treat, and monitor patients with mood disorders, schizophrenia, substance abuse disorders, cognitive disorders and other clinical psychiatric disorders. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Credits (min)
4
Credits (max)
4
Credit unit
Credit
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 895Drug Information APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 896Special Interest APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 897Special Interest APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 898Special Interest APPE4
Subject
PHA
Credits (min)
4
Credits (max)
4
Type
course
Edition
2026-2027
Source
home.hamptonu.edu
PHA 899Advanced Internal

Medicines APPE Lec. 4./Credit 4 This elective rotation is designed to provide the student exposure and experi- ence in comprehensive treatment of disease states of adult patients in specialized internal medicine areas, such as hematology/oncology, ICU, CCU, surgery, general oncology and infectious diseases. Prerequisites: Successful completion of all P-1, P-2, and P-3 level courses.

Subject
PHA
Type
course
Edition
2026-2027
Source
home.hamptonu.edu

Source: Hampton University's catalog, linked per course · table learning_unit · CourseShelf publish 59